The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund

August 20, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Kala Ghoda, Fort Mumbai – 400 051 Mumbai 400 001 Company Symbol: NEOGEN Scrip Code No: 542665 Debt Segment Code: 977028 Subject: Disclosure pursuant to Regulation 29 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 (“SEBI SAST Regulations) Dear Sir/ Madam, We wish to inform that the Company has received attached disclosure on August 19, 2026 from SBI Funds Management Limited (“SBI”) pursuant to Regulation 29(2) of SEBI SAST Regulations, informing the Company about the change in the shareholding of SBI Mutual Fund under its various schemes (“SBI MF”) in Neogen Chemicals Limited (“the Target Company”), decreasing by 2% from previous disclosure made by SBI in this respect under regulation 29(2) of SEBI SAST Regulations wherein the reported holding was 8.5930% of the then paid-up capital of the Target Company. SBI MF has sold 2,11,931 shares of the Target Company representing 0.7740% of the paid-up capital of the Target Company. The final holding of SBI MF as at the close of business hours on August 18, 2026, was 16,50,555 shares which represents 6.0280% of the paid-up capital of the Target Company. We request you to please take the above on your record and disseminate the same on your website. Thanking you, For Neogen Chemicals Limited Unnati Kanani Company Secretary and Compliance Officer Mem. No. A35131 Encl.: A/a Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919